Editstock price.

Oct 15, 2020 · Future price of the stock is predicted at 21.770642845038$ (105.577%) after a year according to our prediction system. This means that if you invested $100 now, your current investment may be worth 205.577$ on 2024 November 30, Saturday . As of March 09, 2023, 4:00 PM CST, Editas Medicine Inc’s stock price was $8.20. Editas Medicine Inc is down 6.71% from its previous closing price of $8.79. During the last market session, Editas Medicine Inc’s stock traded between $8.54 and $8.84. Currently, there are 68.79 million shares of Editas Medicine Inc stock available for purchase.The expert’s price target stands at $72, which implies over 44% upside potential. On the date of publication, Josh Enomoto did not have (either directly or indirectly) any positions in the ...1. Paper. Code. **Stock Price Prediction** is the task of forecasting future stock prices based on historical data and various market indicators. It involves using statistical models and machine learning algorithms to analyze financial data and make predictions about the future performance of a stock. The goal of stock price prediction is to ...

Average. $13.93. Current Price. $10.77. Options. Overview. Research & Ratings. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume ...Editas Medicine (EDIT) Stock Price Performance. Editas Medicine (EDIT) Stock Key Data. Summary Additional Data Analysts Historical Quotes. Key Data. Previous Close. 10.65. Open. 10.60. Day’s Range. EDIT Stock 12 Months Forecast. $12.60. (43.51% Upside) Based on 12 Wall Street analysts offering 12 month price targets for Editas Medicine in the last 3 months. The average price target is $12.60 with a high forecast of $19.00 and a low forecast of $7.00. The average price target represents a 43.51% change from the last price of $8.78.

With a price/sales ratio of 29.63, EDITAS MEDICINE INC has a higher such ratio than 96.08% of stocks in our set. With a year-over-year growth in debt of 83.57%, EDITAS MEDICINE INC's debt growth rate surpasses 88.55% of about US stocks. As for revenue growth, note that EDIT's revenue has grown -39.26% over the past 12 months; that beats …

In depth view into EDIT (Editas Medicine) stock including the latest price, news, dividend history, earnings information and financials. Editas Medicine Inc (EDIT) 10.66 +0.08 ( +0.71% ) USD | NASDAQ | Nov 27, 16:001y 3y 5y max Mountain-Chart Compare with Compare with up to 5 Stocks On Wednesday morning 11/29/2023 the Editas Medicine Inc share started trading at the price of $10.87. Compared to the closing...Interactive Chart for Editas Medicine, Inc. (EDIT), analyze all the data with a huge range of indicators. DOGE. DOGECOIN. 0.068756 +0.000462 +0.68%. ADA. CARDANO. 0.2938 +0.0033 +1.14%. Data is Powered by investing.com ™. Dogecoin (DOGE) prices - Nasdaq offers cryptocurrency prices & market activity ...

EDIT stock peaked early in the year at $90.58 on Jan. 8, but then tumbled to $31.29 on May 10. Since then, the gene-editing company stock rose to $72.94 on Sept. 2 only to immediately tumble again ...

The stock closed at $12.25 on Wednesday and opened at only $9.90 on Thursday, falling to as low as $9.61 in early trading. The stock bounced back a bit toward the end of the day but was still down ...24 มี.ค. 2566 ... ... Pricing · Case studies; Resources. Contact Sales · Sign in · Get started free. English. Language. Get started free. Toggle navigation menu.Mar 6, 2023 · As of March 06, 2023, 4:00 PM CST, Editas Medicine Inc’s stock price was $8.57. Editas Medicine Inc is down 4.35% from its previous closing price of $8.96. During the last market session, Editas Medicine Inc’s stock traded between $8.74 and $9.18. Currently, there are 68.79 million shares of Editas Medicine Inc stock available for purchase. Price Target. Based on short-term price targets offered by 13 analysts, the average price target for Editas Medicine comes to $13.85. The forecasts range from a low of $7.00 to a high of $30.00 ...The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the ...

The Editas Medicine, Inc stock price gained 0.86% on the last trading day (Friday, 24th Nov 2023), rising from $10.49 to $10.58. During the last trading day the stock fluctuated 3.71% from a day low at $10.50 to a day high of $10.89. The price has risen in 6 of the last 10 days and is up by 34.43% over the past 2 weeks.Analyst Forecast. According to 13 analysts, the average rating for EDIT stock is "Buy." The 12-month stock price forecast is $14.17, which is an increase of 33.93% from the latest price.The stock price of Editas plunged 19% in yesterday’s trading session after the company shared interim data for its EDIT 101 - a CRISPR-based treatment for Leber congenital amaurosis. The data ...7.67. -0.20. -2.54%. The mean of analysts' price targets for Editas (EDIT) points to a 72.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong ...Why Editas Medicine Stock Is Soaring Today. What happened Shares of Editas Medicine (NASDAQ: EDIT) were soaring 11.2% higher as of 10:41 a.m. ET on Friday after ...Stock Manager is a powerful WooCommerce stock management plugin that allows you to manage product stock and their variations from one screen. Edit and manage product stock status, quantity, prices, SKU, taxes. etc., apply quick filters and view stock history, import and export stock data to CSV. Stock Manager for WooCommerce plugin is ...

Dec 1, 2023 · According to 12 stock analysts, the average 12-month stock price forecast for EDIT stock stock is $14.17, which predicts an increase of 31.81%. The lowest target is $7.00 and the highest is $36. On average, analysts rate EDIT stock stock as a buy. 27 ต.ค. 2566 ... Shutterstock Lets You Use AI to Edit Stock Photos. Available on any ... price, but most seem to include a one-month free trial. If you want ...

EDIT Stock Analysis Overview What this means: Editas Medicine Inc. (EDIT) gets an Overall Rank of 60, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value.For Editas Medicine stock forecast for 2031, 12 predictions are offered for each month of 2031 with average Editas Medicine stock forecast of $8.2, a high forecast of $8.21, and a low forecast of $8.19. The average Editas Medicine stock forecast 2031 represents a 4.21% increase from the last price of $7.86999988555908.Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report. Pfizer Inc. (PFE): Free Stock Analysis Report. Moderna, Inc. (MRNA): Free Stock Analysis Report ...Its valuation remains in the stratosphere. Its price-to-sales (P/S) multiple is absurdly high, at 33.4. For reference, the biotech industry's average P/S multiple is 5.4. In other words, there's ...Trending Cryptocurrencies. Ripple (XRP) prices - Nasdaq offers cryptocurrency prices & market activity data for US and global markets.Current. -$0.61. 1 Month Ago. -$0.58. 3 Months Ago. -$0.60. Editas Medicine Inc. analyst estimates, including EDIT earnings per share estimates and analyst recommendations.Feb 17, 2021 · Current Price. $10.77. Price as of December 1, 2023, 4:00 p.m. ET. In a field that's becoming more crowded, what will set Editas apart? Mar 30, 2023 · Reason to sell No. 2: Not enough cash. Developing gene-editing therapies is expensive. The company's pipeline of therapies targets a multitude of diseases, including sickle cell anemia, beta ... All transactions on Groww are safe and secure. Users can invest through SIP or Lumpsum using Netbanking through all supported banks. It uses BSE Star MF (with ...

NVDA. NVIDIA Corporation Common Stock. $435.70 -0.93 -0.21%. Editas Medicine, Inc. Common Stock (EDIT) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US ...

Current. -$0.61. 1 Month Ago. -$0.58. 3 Months Ago. -$0.60. Editas Medicine Inc. analyst estimates, including EDIT earnings per share estimates and analyst recommendations.

Nov 24, 2023 · Editas Medicine Stock Forecast 11-26-2023. Forecast target price for 11-26-2023: $ 10.97. Positive dynamics for Editas Medicine shares will prevail with possible volatility of 3.528%. Pessimistic target level: 10.80. Optimistic target level: 11.19. Nov 24, 2023 · Stock analysis for Editas Medicine Inc (EDIT:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Just type out the tickers in a column, then use the cells in your first argument. Since our ticker code is in cell C4, you'd type out. . Below is a list of stocks with their corresponding current prices. If you want to track a list of attributes, you can type them out in separate cells like in the above image.The 3 Best Gene Editing Stocks on the Frontier of Medicine. Find the latest Editas Medicine, Inc. (EDIT) stock quote, history, news and other vital information to help you with your stock...Find out the direct holders, institutional holders and mutual fund holders for Editas Medicine, Inc. (EDIT).Accused cop killer Billy Richards gets some sketchy advice from his lawyer. Edit the first half of this award winning short film. Download 41 min of footage!Zacks Equity Research. March 24, 2023 at 11:30 AM · 3 min read. A month has gone by since the last earnings report for Editas Medicine (EDIT). Shares have lost about 21% in that time frame ...Editas Medicine (EDIT) stock climbs 12% on Friday and 7% in the pre-market hours today, after the company beat estimates for both earnings and revenues in first-quarter 2023. Pipeline progress in ...

DraftKings (NASDAQ:DKNG) was upgraded to Buy from Neutral at MoffettNathanson, with its price target raised by $6.00 to $37.00. Find the latest Editas Medicine, Inc. (EDIT) stock quote, history, news and other vital information to help you with your stock trading and investing.In April 2023, gene editing stocks jumped on positive speculation regarding a positive update from Crispr. Fellow contributor Josh Enomoto flagged both EDIT and CRSP as likely breakout stocks for ...Find the latest Editas Medicine, Inc. (EDIT) stock quote, history, news and other vital information to help you with your stock trading and investing.Instagram:https://instagram. fidelity net worthgartner inc. stockwhat is the best malpractice insurance for nursesmedtronic plc stock price You will also not be allowed to specify the re-order level and select the Cost of sales, Stock control and Input tax accounts. To create a Stock item - Bills ... fake share tradingintegra credit interest rate The Editas Medicine, Inc stock price gained 0.86% on the last trading day (Friday, 24th Nov 2023), rising from $10.49 to $10.58. During the last trading day the stock fluctuated 3.71% from a day low at $10.50 to a day high of $10.89. The price has risen in 6 of the last 10 days and is up by 34.43% over the past 2 weeks. dental and vision insurance for self employed Now, go to File > Manage Feeds. Next, in the Feeds window, enter the URL of the stock market feed that you want to keep a check on, and then press the Add button. At last, tick its checkbox and ...Dec 1, 2023 · See the latest Editas Medicine Inc stock price (EDIT:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Mar 10, 2023 · As of March 10, 2023, 4:00 PM CST, Editas Medicine Inc’s stock price was $7.83. Editas Medicine Inc is down 4.51% from its previous closing price of $8.20. During the last market session, Editas Medicine Inc’s stock traded between $8.10 and $8.91. Currently, there are 68.79 million shares of Editas Medicine Inc stock available for purchase.